Related Funds
| Fund Name | Location |
| Alante Capital | New York, New York, United States |
| Alberts Impact Capital | Australia, New South Wales, Sydney |
| Apodaca Investment Offshore | - |
| Atinum Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| Bailibowen | Beijing, Beijing, China |
| Cattles Invoice Finance | Abingdon, Oxfordshire, United Kingdom |
| Clyde Blowers Capital | Scotland, South Lanarkshire, United Kingdom |
| Crevisse | Seoul, Seoul-t'ukpyolsi, South Korea |
| Erwin Investments | Nebraska, Omaha, United States |
| Genmar Holdings | Minneapolis, Minnesota, United States |
| LongueVue Capital | Louisiana, Metairie, United States |
| Mack Real Estate Group | - |
| Partners Innovation Fund | Boston, Massachusetts, United States |
| Tamarix Capital | New York, New York, United States |
| Vatel Capital | France, Ile-de-France, Paris |
| Working Opportunity Fund | British Columbia, Canada, Vancouver |
| Xinhe Caifu (Beijing) Fund Management | Beijing, Beijing, China |
| Yosemite | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MDmetrix | $10M | 11 Sep 2023 | Seattle, Washington, United States | ||
Cyted | $18M | 17 May 2023 | Cambridge, England, United Kingdom | ||
PsycApps | $2M | 01 Sep 2022 | London, England, United Kingdom | ||
Suvera | $6M | 28 Jul 2022 | London, England, United Kingdom | ||
SimpliFed | $6M | 10 May 2022 | Ithaca, New York, United States | ||
Apnimed | $62M | 04 May 2022 | Cambridge, Massachusetts, United States | ||
Igenesis | $15M | 08 Mar 2022 | Shanghai, China | ||
Accro Bioscience | $50M | 04 Jan 2022 | Suzhou, Jiangsu, China | ||
Huckleberry Labs | $12M | 04 Nov 2021 | Irvine, California, United States |
– MedRhythms announced the closing of a $25m Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates.
– The proceeds from the Series B financing will enable MedRhythms to expand its team and key corporate functions as the company commercializes its flagship product for chronic stroke survivors with walking deficits and advances its digital therapeutics pipeline.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MDmetrix | $10M | 11 Sep 2023 | Seattle, Washington, United States | ||
Cyted | $18M | 17 May 2023 | Cambridge, England, United Kingdom | ||
PsycApps | $2M | 01 Sep 2022 | London, England, United Kingdom | ||
Suvera | $6M | 28 Jul 2022 | London, England, United Kingdom | ||
SimpliFed | $6M | 10 May 2022 | Ithaca, New York, United States | ||
Apnimed | $62M | 04 May 2022 | Cambridge, Massachusetts, United States | ||
Igenesis | $15M | 08 Mar 2022 | Shanghai, China | ||
Accro Bioscience | $50M | 04 Jan 2022 | Suzhou, Jiangsu, China | ||
Huckleberry Labs | $12M | 04 Nov 2021 | Irvine, California, United States |
